// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























28841 Abstracts

Association of Air Pollution with Incidence of Asthma, Allergic Rhinitis and Eczema: 10-Year Follow-Up of the Toronto Child Health Evaluation Questionnaire (T-CHEQ) Study

T. M. To - American Thoracic Society (ATS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Gastroenterology (GU)

N/A

N/A

Airway Epithelial Repair: Cell Subtypes or Proliferation/Differentiation Dependent?

G. K. Singhera - American Thoracic Society (ATS) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Inhibitory Activity of STAT6-IP on IL-33-Mediated-IL-13 Production and Macrophage Polarization in an Innate Murine Allergy Model

V. Moarbes - American Thoracic Society (ATS) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

The Effect of Cd4+ T Cell Derived Heparin-Binding Epidermal Growth Factor in a Model of Acute Allergic Asthma

S. Farahnak - American Thoracic Society (ATS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

N/A

SK1211

Murine Sensitization with House-Dust Mite Extract Alters the Immune Response Towards H1N1

K. Shahangian - American Thoracic Society (ATS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

N/A

IFN-lambda

Corticosteroid Insensitivity of Monocyte-Derived Macrophages from Severe Neutrophilic Asthmatics Is Not Associated with Differentiation Bias

N. Dauletbaev - American Thoracic Society (ATS) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Interleukin

Adverse Events Associated with Oral Corticosteroids in Asthma

K. S. Al Efraij - American Thoracic Society (ATS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

N/A

N/A

Treatment with a CD200 Receptor Agonist Aptamer Attenuates Airway Hyperresponsiveness, Airway Inflammation, and Remodelling in a Chronic Murine Model of HDM-Induced Airways Inflammation

L. Woo - American Thoracic Society (ATS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

N/A

SK1211

Preclinical Experiments Support Recent Clinical Switch to Delivered Dose During Methacholine Bronchoprovocation Testing

O. Schmid - American Thoracic Society (ATS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

N/A

SK1211

What’s Behind the White Coat: Potential Mechanisms of Physician-Attributable Variation in Critical Care

J. Hart - American Thoracic Society (ATS) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Electronic Medical Records in Interstitial Lung Disease: Implementation of Monitoring Flowsheets for Lung Physiology

F. Chowdhury - American Thoracic Society (ATS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

N/A

N/A

Daily Activity Trackers and Home Spirometry in Patients with Idiopathic Pulmonary Fibrosis

V. Marcoux - American Thoracic Society (ATS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

N/A

N/A

Comparison of Transbronchial Lung Cryobiopsy with Surgical Lung Biopsy in the Diagnosis of Interstitial Lung Disease

C. Ruel - American Thoracic Society (ATS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

N/A

N/A

Physiological Impairment in Patients with Interstitial Lung Disease at the Time of Referral to a Specialty Clinic

P. Jamali - American Thoracic Society (ATS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

N/A

N/A

The Prevalence and Risk Factors of Osteoporosis in Individuals with Chronic Obstructive Pulmonary Disease (COPD): A Systematic Review and Meta-Analysis

Y. Chen - American Thoracic Society (ATS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

N/A

N/A

Lung Fissure Interruption on Computer Tomography Imaging as a Diagnostic Tool for Interlobar Fusion

T. Vandemoortele - American Thoracic Society (ATS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

N/A

N/A

Proteomic, Metabolomic and Lipidomic Deficiencies in Human Sepsis Compared to Health - Preliminary Study

K. Roveran Genga - American Thoracic Society (ATS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

N/A

vasopressin Injection

Depletion of Components of the Hepatic Malate-Aspartate Shuttle May Limit Energy Utilization in Pseudomonas Aeruginosa Septic Shock in Dogs

S. N. Mink - American Thoracic Society (ATS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

N/A

N/A

Mesenchymal Stromal/Stem Cells Enhance Macrophage Phagocytosis and Clearance in Preclinical Sepsis Models Via Enhanced Macrophage Hemoxygenase-1 Expression

M. Jerkic - American Thoracic Society (ATS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

N/A

N/A

The Physiological Determinants of Cerebral Oxygenation During the First 24 Hours of Critical Illness

M. D. Wood - American Thoracic Society (ATS) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Copyright © 2026. QuantiNova All rights reserved